Lineage Cell Therapeutics
LCTX
#7510
Rank
S$0.48 B
Marketcap
S$2.12
Share price
4.75%
Change (1 day)
205.99%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2025 (TTM): -S$26.85 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are S$10.81 Million. In 2024 the company made an earning of -S$27.52 Million, an increase over its 2023 earnings that were of -S$31.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$26.85 Million-2.42%
2024 -S$27.52 Million-13.16%
2023 -S$31.69 Million9.83%
2022 -S$28.85 Million-54.24%
2021 -S$63.04 Million86.07%
2020 -S$33.88 Million-31.97%
2019 -S$49.8 Million-5.42%
2018 -S$52.66 Million1.1%
2017 -S$52.08 Million-31.06%
2016 -S$75.54 Million-10.38%
2015 -S$84.29 Million29.69%
2014 -S$65 Million31.68%
2013 -S$49.36 Million
2011 -S$23.96 Million89.78%
2010 -S$12.63 Million206.06%
2009 -S$4.13 Million-0.58%
2008 -S$4.15 Million164.89%
2007 -S$1.57 Million-30.22%
2006 -S$2.25 Million
2002 -S$2.61 Million-41.04%
2001 -S$4.43 Million-32.04%
2000 -S$6.51 Million-11.85%
1999 -S$7.38 Million
1997 -S$4.74 Million12.12%
1996 -S$4.23 Million106.25%
1995 -S$2.05 Million-11.11%
1994 -S$2.31 Million50%
1993 -S$1.54 Million20%
1992 -S$1.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.19 Billion 627.71%๐Ÿ‡บ๐Ÿ‡ธ USA